Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
2.600
+0.030 (1.17%)
At close: Dec 20, 2024, 4:00 PM
2.570
-0.030 (-1.15%)
After-hours: Dec 20, 2024, 4:40 PM EST
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $20.09 million as of December 20, 2024. Its market cap has decreased by -85.24% in one year.
Market Cap
20.09M
Enterprise Value
2.50M
1-Year Change
-85.24%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $20.09M, a decrease of -34.56%. That is a compound annual growth rate of -5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 18.80M | -84.37% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VSee Health | 20.68M |
| American Shared Hospital Services | 20.67M |
| Ocean Biomedical | 20.51M |
| Bionano Genomics | 20.45M |
| NKGen Biotech | 20.35M |
| MiNK Therapeutics | 19.78M |
| BioLineRx | 19.37M |
| Affimed | 19.34M |